Skip to content

Clinical trials

Glomerulonephritis, IGA trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis, IGA Country / region: South Korea Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20111
20131
20141
20161
20184
20193
20203
20215
20225
20234
20243
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting10
Active, not recruiting8
Terminated3
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals11
Alexion Pharmaceuticals, Inc.5
Otsuka Pharmaceutical Development & Commercialization, Inc.3
Yonsei University3
Calliditas Therapeutics AB2
Seoul National University Hospital2
ADARx Pharmaceuticals, Inc.1
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Alpine Immune Sciences, Inc.1
Anthera Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis, IGA40
Glomerulonephritis10
Renal Insufficiency, Chronic10
Kidney Diseases9
Proteinuria9
Urologic Diseases7
Lupus Nephritis5
Autoimmune Diseases3
Diabetic Nephropathies3
Glomerulosclerosis, Focal Segmental3

Trials

Showing 26 to 40 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.